Krystyna Ossowska

2.9k total citations
109 papers, 2.4k citations indexed

About

Krystyna Ossowska is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Krystyna Ossowska has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Cellular and Molecular Neuroscience, 50 papers in Neurology and 32 papers in Molecular Biology. Recurrent topics in Krystyna Ossowska's work include Neuroscience and Neuropharmacology Research (67 papers), Neurological disorders and treatments (38 papers) and Parkinson's Disease Mechanisms and Treatments (32 papers). Krystyna Ossowska is often cited by papers focused on Neuroscience and Neuropharmacology Research (67 papers), Neurological disorders and treatments (38 papers) and Parkinson's Disease Mechanisms and Treatments (32 papers). Krystyna Ossowska collaborates with scholars based in Poland, Germany and Czechia. Krystyna Ossowska's co-authors include S. Wolfarth, Jadwiga Wardas, Stanisław Wolfarth, Jolanta Konieczny, Katarzyna Kuter, Andrzej Pilc, M. Pietraszek, Elżbieta Lorenc‐Koci, G. Schulze and Joanna M. Wierońska and has published in prestigious journals such as PLoS ONE, Brain Research and Neuroscience.

In The Last Decade

Krystyna Ossowska

108 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krystyna Ossowska Poland 28 1.7k 891 759 255 229 109 2.4k
Jadwiga Wardas Poland 29 1.5k 0.9× 922 1.0× 776 1.0× 133 0.5× 230 1.0× 81 2.4k
André Nieoullon France 33 1.9k 1.1× 542 0.6× 924 1.2× 466 1.8× 282 1.2× 78 2.7k
Luisa Ugedo Spain 29 1.7k 1.0× 550 0.6× 879 1.2× 297 1.2× 357 1.6× 95 2.5k
Marti Santiago Spain 25 1.2k 0.7× 547 0.6× 581 0.8× 183 0.7× 291 1.3× 66 2.0k
Annalisa Pinna Italy 37 1.8k 1.1× 1.2k 1.3× 1.1k 1.4× 179 0.7× 147 0.6× 94 3.2k
Yoshimi Misu Japan 34 2.2k 1.3× 535 0.6× 1.4k 1.9× 213 0.8× 707 3.1× 210 3.6k
Marc Marien France 32 1.5k 0.9× 671 0.8× 803 1.1× 343 1.3× 343 1.5× 48 2.6k
Christophe Melon France 24 1.3k 0.8× 571 0.6× 543 0.7× 234 0.9× 153 0.7× 46 1.8k
Maria Rosaria Domenici Italy 29 1.4k 0.8× 349 0.4× 712 0.9× 301 1.2× 208 0.9× 78 2.3k
I.A. Paterson Canada 25 1.0k 0.6× 391 0.4× 594 0.8× 109 0.4× 125 0.5× 48 1.8k

Countries citing papers authored by Krystyna Ossowska

Since Specialization
Citations

This map shows the geographic impact of Krystyna Ossowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krystyna Ossowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krystyna Ossowska more than expected).

Fields of papers citing papers by Krystyna Ossowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krystyna Ossowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krystyna Ossowska. The network helps show where Krystyna Ossowska may publish in the future.

Co-authorship network of co-authors of Krystyna Ossowska

This figure shows the co-authorship network connecting the top 25 collaborators of Krystyna Ossowska. A scholar is included among the top collaborators of Krystyna Ossowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krystyna Ossowska. Krystyna Ossowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ossowska, Krystyna. (2019). Zona incerta as a therapeutic target in Parkinson’s disease. Journal of Neurology. 267(3). 591–606. 52 indexed citations
2.
Kuter, Katarzyna, et al.. (2016). Adaptation within mitochondrial oxidative phosphorylation supercomplexes and membrane viscosity during degeneration of dopaminergic neurons in an animal model of early Parkinson's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(4). 741–753. 41 indexed citations
3.
Ossowska, Krystyna, et al.. (2014). Apomorphine enhances harmaline-induced tremor in rats. Pharmacological Reports. 67(3). 435–441. 14 indexed citations
4.
Kuter, Katarzyna, Przemysław Nowak, Krystyna Gołembiowska, & Krystyna Ossowska. (2010). Increased Reactive Oxygen Species Production in the Brain After Repeated Low-Dose Pesticide Paraquat Exposure in Rats. A Comparison with Peripheral Tissues. Neurochemical Research. 35(8). 1121–1130. 37 indexed citations
5.
Wernicke, Catrin, Barbara A. Zieba, Katarzyna Kuter, et al.. (2010). 9-Methyl-β-carboline has restorative effects in an animal model of Parkinson’s disease. Pharmacological Reports. 62(1). 35–53. 43 indexed citations
6.
Lorenc‐Koci, Elżbieta, Hans Rommelspacher, G. Schulze, et al.. (2006). Parkinson??s disease-like syndrome in rats induced by 2,9-dimethyl-??-carbolinium ion, a ??-carboline occurring in the human brain. Behavioural Pharmacology. 17(5-6). 463–473. 13 indexed citations
7.
Ossowska, Krystyna, Jolanta Konieczny, S. Wolfarth, & Andrzej Pilc. (2005). MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. Neuropharmacology. 49(4). 447–455. 42 indexed citations
8.
Ossowska, Krystyna, Jolanta Konieczny, Andrzej Pilc, & Stanisław Wolfarth. (2002). The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors. Brain Research. 950(1-2). 88–94. 10 indexed citations
9.
Ossowska, Krystyna, M. Pietraszek, Jadwiga Wardas, et al.. (2000). The role of glutamate receptors in antipsychotic drug action. Amino Acids. 19(1). 87–94. 35 indexed citations
10.
Konieczny, Jolanta, Krystyna Ossowska, G. Schulze, H. Coper, & Stanisław Wolfarth. (1999). L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats. Psychopharmacology. 143(3). 235–243. 18 indexed citations
11.
Wolfarth, S., Elżbieta Lorenc‐Koci, G. Schulze, et al.. (1997). Age-related muscle stiffness: predominance of non-reflex factors. Neuroscience. 79(2). 617–628. 15 indexed citations
12.
Wolfarth, S., Jolanta Konieczny, Maria Śmiałowska, G. Schulze, & Krystyna Ossowska. (1996). Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements. Neuroscience. 74(4). 985–996. 32 indexed citations
13.
Ossowska, Krystyna. (1995). The subsensitivity of striatal glytamate receptors induced by chronic haloperidol in rats. Acta Neurobiologiae Experimentalis. 55(5). 1 indexed citations
14.
Ossowska, Krystyna & Stanisław Wolfarth. (1995). Stimulation of glutamate receptors in the intermediate/caudal striatum induces contralateral turning. European Journal of Pharmacology. 273(1-2). 89–97. 29 indexed citations
15.
Lorenc‐Koci, Elżbieta, Krystyna Ossowska, Jadwiga Wardas, & S. Wolfarth. (1995). Does reserpine induce parkinsonian rigidity?. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 9(2-3). 211–223. 30 indexed citations
16.
Ossowska, Krystyna. (1995). The subsensitivity of striatal glutamate receptors induced by chronic haloperidol in rats. European Journal of Pharmacology. 294(2-3). 685–691. 8 indexed citations
17.
Ossowska, Krystyna, Elżbieta Lorenc‐Koci, & S. Wolfarth. (1994). Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: A mechanomyographic analysis. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 7(2). 143–152. 25 indexed citations
18.
Wolfarth, S., et al.. (1992). MUSCLE WEAKNESS AND CONTINUOUS EMG ACTIVITY IN SENILE RATS; AN ANIMAL MODEL OF SPASTICITY?. Behavioural Pharmacology. 3(Supplement). 81–81. 2 indexed citations
19.
Wolfarth, Stanisław & Krystyna Ossowska. (1989). Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 13(6). 799–840. 41 indexed citations
20.
Kolasiewicz, Wacław, A.R. Cools, Krystyna Ossowska, & S. Wolfarth. (1987). The neostriatal inhibition of catalepsy, but not of muscle rigidity, evoked from the substantia nigra pars reticulata. Pharmacology Biochemistry and Behavior. 28(4). 453–457. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jadwiga Wardas Breakdown of academic impact, for papers by André Nieoullon Breakdown of academic impact, for papers by Luisa Ugedo Breakdown of academic impact, for papers by Marti Santiago Breakdown of academic impact, for papers by Annalisa Pinna Breakdown of academic impact, for papers by Yoshimi Misu Breakdown of academic impact, for papers by Marc Marien Breakdown of academic impact, for papers by Christophe Melon Breakdown of academic impact, for papers by Maria Rosaria Domenici Breakdown of academic impact, for papers by I.A. Paterson
Rankless by CCL
2026